Robert Goldsby, MD
Honors and Awards
- Exceptional Physician Award, UCSF Medical Center, 2013
Websites
Publications
- P76. An analysis of prognostic factors for patients with primary osseous malignancies of the mobile spine in the California Cancer Registry, 1988-2016.
- Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
- Clinical characteristics and outcomes of infants compared with children diagnosed with rhabdomyosarcoma: Analysis of surveillance, epidemiology and end results data from 2000 to 2016.
- 3 Dimensions of Treatment Decision Making in Adolescents and Young Adults With Cancer.
- Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.
- Frequency of face touching with and without a mask in pediatric hematology/oncology health care professionals.
- A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors.
- Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.
- High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.
- Impact of low-income public insurance on survival for children and young adults with bone and soft tissue sarcomas.
- Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
- Treatment Decision-Making Involvement in Adolescents and Young Adults With Cancer.
- A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
- Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
- Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
- Late Effects of Treatment and Palliative Care.
- Pocket Reference Card Improves Pediatric Resident Comfort in Caring for Children at End of Life.
- Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.
- Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
- Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors.
- RO-02CEREBRAL MICROBLEEDS ARE ASSOCIATED WITH WORSE EXECUTIVE FUNCTION IN PEDIATRIC BRAIN TUMOR SURVIVORS.
- Clinical Characteristics and Outcomes of Pediatric Patients with Desmoplastic Small Round Cell Tumor.
- Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.
- Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT.
- Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
- Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
- Recurrent stroke in childhood cancer survivors.
- Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
- Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
- Intestinal obstruction in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).
- Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
- Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.
- Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
- Clinical features, outcomes, and prognostic factors in patients with extraskeletal osteosarcoma.
- Adolescent and young adult oncology, version 2.2014.
- Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma.
- Comparison of Latino and non-Latino patients with Ewing sarcoma.
- Adverse impact of regional lymph node involvement in osteosarcoma.
- Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study.
- Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
- Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.
- Adolescent and young adult oncology. Clinical practice guidelines in oncology.
- Clinical features and outcomes in patients with secondary Ewing sarcoma.
- Evaluation of plasma annexin V levels in children and young adults with solid tumors.
- CNS demyelination in fibrodysplasia ossificans progressiva.
- Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
- Abstract 8: Radiation and modifiable Stroke Risk Factors in adult Survivors of Pediatric Cancer: Results from the Childhood Cancer Survivor Study.
- Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.
- Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
- Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT.
- Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
- Survivors of childhood cancer have increased risk of gastrointestinal complications later in life.
- Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
- Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
- Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation.
- Patellar metastatic melanoma in a 13-year-old boy.
- Osteoid osteoma of the femur in a 7-month-old infant treated with radiofrequency ablation.
- Osteosarcoma in children 5 years of age or younger at initial diagnosis.
- Polymerase delta and epsilon proofreading cooperate with MMR to suppress lethal mutations and cancer in mice.
- Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging.
- Ethnic and racial differences in patients with Ewing sarcoma.
- Late Effects of Treatment and Palliative Care.
- Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
- DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.
- Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
- Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.
- Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
- Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.
- Meta[131I]iodobenzylguanidine therapy for patients with metastatic and unresectable pheochromocytoma and paraganglioma.
- Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers.
- Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician.
- Receptor imaging of pediatric tumors: clinical practice and new developments.
- Fibrodysplasia ossificans progressiva.
- PET/CT Staging und Restaging maligner Tumore bei Kindern und Jugendlichen.
- Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
- Successful Treatment of Pediatric Desmoids Using Radiation as a Component of Multimodality Therapy.
- Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.
- Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.
- Immunotherapy for severe aplastic anemia following orthotopic liver transplantation in children.
- Effect of chemotherapy on initial compressive osseointegration of tumor endoprostheses.
- Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
- Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma.
- Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
- Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
- Solid organ second malignant neoplasms among children diagnosed with malignant bone tumors treated on Children Cancer Study Group/Pediatric Oncology Group protocols after 1980.
- Surviving childhood cancer: the impact on life.
- Oncologic approaches to pediatric limb preservation.
- Pediatric malignancies. Case 2. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease.
- Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia.
- A phase II study of 131 I-MIBG for refractory neuroblastoma.
- Temozolomide and intravenous irinotecan for refractory Ewing’s sarcoma: A retrospective review.
- Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma.
- Chapter 162 Leukemias.
- Chapter 163 Lymphomas.
- Surviving childhood cancer; now what? Controversies regarding long-term follow-up.
- Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.
- Neuroblastoma: evolving therapies for a disease with many faces.
- Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer.
- Ig gene somatic hypermutation in mice defective for DNA polymerase delta proofreading.
- Dapsone therapy for children with immune thrombocytopenic purpura.
- Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification.
- Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.
- High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.
- Unexpected pleural effusions in 3 pediatric patients treated with STI-571.
- Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice.
- Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity.
- Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia.
- The molecular biology of pediatric lymphomas.
- Spindle cell sarcoma of the kidney with ganglionic elements (malignant ectomesenchymoma) associated with chromosomal abnormalities and a review of the literature.
- Mouse DNA polymerase delta gene (Pold1) maps to chromosome 7.
- Mouse DNA polymerase epsilon gene (Pole) maps to chromosome 5.
- Lymphoblast morphology in predicting leukemic meningeal relapse with low chamber count and lymphoblasts.
- Pediatric pulmonary artery thromboembolism: an illustrative case.